Clinical Trial Update: Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

View source ↗

Summary

A Pfizer-sponsored observational trial update in Colombia reports patient characteristics, treatment patterns, and incidence of events such as discontinuation a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Oral anticoagulants (various)

Snippet

Sponsor: Pfizer | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2025-02-06